Received: 18 October 2021
Accepted: 29 April 2022
First Online: 13 May 2022
: Participants provided informed consent prior to completing the survey. This study received a Category 2 exemption from the Purdue University Biomedical Institutional Review Board (IRB-2020–1366). All research activities were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.